NCT03698617View on ClinicalTrials.gov

A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486

PHASE2CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

December 6, 2016

Primary Completion Date

June 29, 2018

Study Completion Date

July 18, 2018

Conditions

Induction of General Anaesthesia

Interventions

DRUG

HSK3486

For induction of general anesthesia In dose escalation cohort: Starting from 0.4mg/kg, up-titration dose by 0.1mg/kg until 0.8mg//kg or down-titration dose by 0.1mg/kg until 0.1mg/kg based on the efficacy and safety results.

DRUG

Propofol

For induction of general anesthesia

Trial Locations (1)

325027

The 2nd Affiliated Hospital of WMU, Wenzhou

All Listed Sponsors

lead

Sichuan Haisco Pharmaceutical Group Co., Ltd

INDUSTRY

NCT03698617 - A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486 | Biotech Hunter | Biotech Hunter